News
- In the news
Accelerating pharma innovation with Norstella and AWS
Our CEO, Kris Joshi, joined industry leaders at the second annual AWS Healthcare Investor and Executive Summit to discuss how technology and AI are shaping the future of healthcare and life sciences. He highlights the challenge that critical data is often fragmented across many sources,…
- Press Releases
Norstella appoints Dan Tempesta as Chief Financial Officer
- Press Releases
Norstella appoints Kris Joshi as Chief Executive Officer
- Press Releases
Panalgo revolutionizes real-world data with launch of LinQNotes and Ella AI
- Press Releases
Norstella named to Fast Company’s annual list of the world’s most innovative companies of 2025
Insights
- Article
Inside Norstella’s innovation engine: How the next generation of real-world data gets you closer to the patient
Real-world data (RWD) is transforming the life sciences industry, giving pharma companies valuable insights into the patient journey and helping more people get the life-saving treatments they need. To discuss the power of real-world data, where it’s headed, and how it’s fueling Norstella’s next generation…
- Article
Real-world data in 2025 and beyond: Closing the strategy gap
Pharma leaders agree that real-world data (RWD) is essential—but many still struggle to harness its full potential. In Real-World Data in 2025 and Beyond: Closing the Strategy Gap, Norstella surveyed 200 life sciences executives to uncover how organizations are using RWD, where they’re falling short,…
- Article
Pharma’s real-world data dilemma: Strategic asset or wasted resource?
Every day, patients are experiencing the life-changing impact of real-world data (RWD), and life sciences companies are feeling the business impact, too. RWD is no doubt helping pharma companies better understand the patient journey and get life-saving therapies to market faster, according to Norstella’s recent…
- Article
The growing strategic influence of market access
Market access professionals tell us that their role is becoming increasingly influential amid a turbulent policy environment and intense competitive landscape. This was one of the clearest results from a survey commissioned by MMIT and The Dedham Group, which we explored in a recent white…
- Article
The R&D implications of market access complexity
Our latest research strongly suggests that a highly dynamic market access situation in the US is feeding back into upstream decisions around R&D strategy. We explored this topic in detail in a recent white paper called Working Backwards: Patient access strategy is now guiding R&D….
Events
- Conference
- December 2025
American Society of Hematology
- Conference
- February 2026
SCOPE
- Conference
- March 2026
DigiPharma Connect
- Conference
- April 2026
AMCP
- Conference
- April 2026
Asembia
- Conference
- May 2026
ISPOR
- Conference
- May 2026
ASCO
- Conference
- June 2026
Future Pharma
- Conference
- August 2026
ISPE
- Conference
- September 2026
Fierce Pharma Week
- Conference
- October 2026
AMCP Nexus
- Conference
- November 2026
ISPOR EU
Work with us
Join our mission
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Get in touch
Let's connect
Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?